Table 3. Relationships between baseline CSVD markers and change of cognitive function.
Change of cognitive function | ||||||||||||
MMSE | Memory | Language | Spatial construction | Attention | Executive function | |||||||
β | P | β | P | β | P | β | P | β | P | β | P | |
WMH volume, per 1% increase | -0.95 | 0.036 | 0.41 | 0.054 | 0.02 | 0.918 | 0.51 | 0.092 | -0.07 | 0.770 | -0.45 | 0.004 |
Lacunes, per No. increase | -0.56 | 0.123 | -0.20 | 0.235 | 0.23 | 0.153 | 0.11 | 0.651 | 0.47 | 0.009 | -0.04 | 0.734 |
CMBs, per No. increase | 0.18 | 0.249 | -0.03 | 0.643 | -0.07 | 0.299 | -0.12 | 0.261 | -0.10 | 0.215 | 0.07 | 0.168 |
ePVS, per score increase | 0.34 | 0.185 | -0.21 | 0.092 | 0.17 | 0.134 | -0.09 | 0.597 | -0.06 | 0.642 | -0.06 | 0.478 |
Adjusted for age, sex, interval, education years, ApoE ε4 carrier
Abbreviations: CSVD= cerebral small vessel disease; WMH = white matter hyperintensities; CMBs = cerebral microbleeds; ePVS = enlarged perivascular spaces; MMSE = Mini-Mental State Examination.